Rational Drug Design and Synthesis of Molecules Targeting the Angiotensin II Type 1 and Type 2 Receptors

Author： Kellici Tahsin F. Tzakos Andreas G. Mavromoustakos Thomas

Publisher： MDPI

E-ISSN： 1420-3049|20|3|3868-3897

ISSN： 1420-3049

Source： Molecules, Vol.20, Iss.3, 2015-03, pp. : 3868-3897

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance

By Xu Hong-Zhao Cheng Yan-Li Wang Wan-Ning Wu Hao Zhang Yuan-Yuan Zang Chong-Sen Xu Zhong-Gao

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 684-684

MDPI

Access to resources Recommend Favorite

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury

By Hwang Ok-Kyung Park Jin-Kyu Lee Eun-Joo Lee Eun-Mi Kim Ah-Young Jeong Kyu-Shik

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 227-227

MDPI

Access to resources Recommend Favorite

Hyperhomocysteinemia Accelerates Collagen Accumulation in the Adventitia of Balloon-Injured Rat Carotid Arteries via Angiotensin II Type 1 Receptor

By Yao Dan Sun Ning-Ling

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-10 ,pp. : 19487-19498

MDPI

Access to resources Recommend Favorite

TRPV1: A Target for Rational Drug Design

By Carnevale Vincenzo Rohacs Tibor

Pharmaceuticals, Vol. 9, Iss. 3, 2016-08 ,pp. : 52-52

MDPI

Access to resources Recommend Favorite

The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design

By Cozza Giorgio

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 26-26

MDPI

Access to resources Recommend Favorite